03/01/2018 14:22:02

Director/PDMR Shareholding

Related content
09 Oct - 
Director/PDMR Shareholding
09 Oct - 
Director/PDMR Shareholding
01 Oct - 
Director/PDMR Shareholding

Stagecoach Group plc

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and their Closely Associated Persons

Yorkshire Building Society (the "Trustee"), as the Trustee of the Company's HM Revenue and Customs approved Stagecoach Group plc 2011 Share Incentive Plan (the "Plan"), notified the Company on 3 January 2018, that it purchased, on 2 January 2018, ordinary shares of 125/228th pence each in the capital of the Company on behalf of, and awarded matching shares to, the following persons discharging managerial responsibility.

The attached notifications, made in accordance with the requirements of the EU Market Abuse Regulation, give further detail of the number of shares purchased and the number of matching shares awarded.

1

Details of the person discharging managerial responsibilities/person closely associated

a) Name Martin Griffiths

2

Reason for the notification

a) Position/status Chief Executive
b) Initial notification/ Amendment This is an initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name Stagecoach Group plc
b) LEI 4L663LRNTBQ008OK2N07

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of instrument Identification code Ordinary shares of 125/228p

ISIN: GB00B6YTLS95

b) Nature of the transaction Partnership shares purchased on behalf of, and matching shares awarded to, the above named person by Yorkshire Building Society (the "Trustee"), as the Trustee of the Company's HM Revenue and Customs approved Stagecoach Group plc 2011 Share Incentive Plan.
c) Price(s) and volume(s) Price(s) Volume(s)
  Partnership shares GBP 1.684 90
  Matching shares GBP 0.00 10
     
d) Aggregated information

- Aggregated volume

- Price

 

Aggregated volume: 100   

GBP 1.515  

 

e) Date of the transaction 2018-01-02
f) Place of the transaction XLON

1

Details of the person discharging managerial responsibilities/person closely associated

a) Name Ross Paterson

2

Reason for the notification

a) Position/status Finance Director
b) Initial notification/ Amendment This is an initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name Stagecoach Group plc
b) LEI 4L663LRNTBQ008OK2N07

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of instrument Identification code Ordinary shares of 125/228p

ISIN: GB00B6YTLS95

b) Nature of the transaction Partnership shares purchased on behalf of, and matching shares awarded to, the above named person by Yorkshire Building Society (the "Trustee"), as the Trustee of the Company's HM Revenue and Customs approved Stagecoach Group plc 2011 Share Incentive Plan.
c) Price(s) and volume(s) Price(s) Volume(s)
  Partnership shares GBP 1.684 90
  Matching shares GBP 0.00 10
     
d) Aggregated information

- Aggregated volume

- Price

 

Aggregated volume: 100   

GBP 1.515

 

e) Date of the transaction 2018-01-02
f) Place of the transaction XLON

1

Details of the person discharging managerial responsibilities/person closely associated

a) Name Robert Andrew

2

Reason for the notification

a) Position/status Managing Director, UK Bus Division (Scotland)
b) Initial notification/ Amendment This is an initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name Stagecoach Group plc
b) LEI 4L663LRNTBQ008OK2N07

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of instrument Identification code Ordinary shares of 125/228p

ISIN: GB00B6YTLS95

b) Nature of the transaction Partnership shares purchased on behalf of, and matching shares awarded to, the above named person by Yorkshire Building Society (the "Trustee"), as the Trustee of the Company's HM Revenue and Customs approved Stagecoach Group plc 2011 Share Incentive Plan.
c) Price(s) and volume(s) Price(s) Volume(s)
  Partnership shares GBP 1.684 90
  Matching shares GBP 0.00 10
     
d) Aggregated information

- Aggregated volume

- Price

 

Aggregated volume: 100   

GBP 1.515 

 

e) Date of the transaction 2018-01-02
f) Place of the transaction XLON

1

Details of the person discharging managerial responsibilities/person closely associated

a) Name Mark Threapleton

2

Reason for the notification

a) Position/status Managing Director, UK Bus Division (England and Wales)
b) Initial notification/ Amendment This is an initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name Stagecoach Group plc
b) LEI 4L663LRNTBQ008OK2N07

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of instrument Identification code Ordinary shares of 125/228p

ISIN: GB00B6YTLS95

b) Nature of the transaction Partnership shares purchased on behalf of, and matching shares awarded to, the above named person by Yorkshire Building Society (the "Trustee"), as the Trustee of the Company's HM Revenue and Customs approved Stagecoach Group plc 2011 Share Incentive Plan.
c) Price(s) and volume(s) Price(s) Volume(s)
  Partnership shares GBP 1.684 90
  Matching shares GBP 0.00 10
     
d) Aggregated information

- Aggregated volume

- Price

 

Aggregated volume: 100   

GBP 1.515 

 

e) Date of the transaction 2018-01-02
f) Place of the transaction XLON

For further information, please contact:

Stagecoach Group plc www.stagecoach.com

Mike Vaux, Company Secretary

01738 442111

3 January 2018


This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Stagecoach Group PLC via Globenewswire

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

Regulatory news

HSBC Bank Plc : Form 8.5 (EPT/RI) - Lonmin PLC

22/02/2018 10:54:53
FORM 8.5 EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Name of exempt principal trader: HSBC BANK PLC (b) Name of offeror/offeree i..

Rathbone Brothers Plc : Preliminary announcement of 2017 results

22/02/2018 07:00:19
Funds under management up 14.3% to £39.1 billionThis is a preliminary statement of annual results published in accordance with FCA Listing Rule 9.7A. It covers the year ended 31 December 2017. Mark Nicholls, Chairman of Rathbone Brothers Plc, said: "UK and global investment markets performed well in 2017, with some indices reaching record levels towards the end of the year. This outcome has b..

Elliott Capital Advisors, L.P : Form 8.3 - GKN Plc

Related news
21/02/2018 15:25:10
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser: Elliott Capital Advisors, L.P. (for itself and related general partners ..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Matinas BioPharma Appoints Global Pharmaceutical Drug Development Industry Leader Theresa Matkovits, Ph.D., Chief Development Officer; Further Expands Manufacturing and Clinical Development Team
2
EyePoint Pharmaceuticals Receives FDA Approval of YUTIQ™ (fluocinolone acetonide intravitreal implant) 0.18 mg
3
JCDecaux: Update on JCDecaux's proposed acquisition of APN Outdoor in Australia
4
Roche launches NGS AVENIO Tumor Tissue Analysis Kits for oncology research
5
ACACIA PHARMA PROVIDES FURTHER UPDATE ON FDA REGULATORY REVIEW OF BARHEMSYS(TM)

Related stock quotes

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Berlingske Media 2018  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
16 October 2018 01:31:45
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20181005.3 - EUROWEB5 - 2018-10-16 02:31:45 - 2018-10-16 01:31:45 - 1000 - Website: OKAY